DNAnexus is a leading cloud-based SaaS company serving the global life science community.
DNAnexus provides a cloud platform for governments, universities, doctors and pharmaceutical companies to tap into DNA and other clinical data sets and collaborate on scientific research projects.
DNAnexus was founded in 2009 by Serafim Batzoglou, Arend Sidow and Andreas Sundquist. The company is headquartered in Mountain View, California.
DNAnexus’ health informatics platform serves customers across a spectrum of industries — government, biopharmaceutical, clinical diagnostics, healthcare, and academic research in 33 countries with compliant protection of data, privacy, and intellectual property.
DNAnexus' platform provides a secure and collaborative environment where genomics, multi-omics, and real world data can be combined with clinical data at scale, providing new insights that can lead to improved diagnostics, new targeted therapies and better patient care.
DNAnexus' platform is used by seven of the world’s top 10 pharmaceutical companies and eight of the 10 biggest diagnostics developers—to single out just a few of its more than 12,000 total users located in four dozen countries across the globe.
DNAnexus is backed by GV, Blackstone, Perceptive Advisors, Northpond Ventures, Foresite Capital, TPG Capital, First Round Capital, Innovatus Capital Partners, and others. The company raised $200M in a new round on Mar 08, 2022. This brings DNAnexus' total funding to $472.6M to date. The latest round valued the company at a $600M post-money.